Point,Care,PoC,Lipid,Test,Mark business, insurance Point of Care (PoC) Lipid Test Market Size, Segmentation To

As we all know to live in this world we have to perform some activity by which we can earn money. There are many activities by which we can earn money and meet the standards to live in this society. And from one of them is franchise.  Franc Small offices have unique needs, and thatincludes document shredding. Designed with the smaller business inmind, the Dahle 20314 is a cross-cut shredder that offers Level 3security and brings you into compliance with federal regulations. The

Global Point of care (PoC) Lipid Test market is expected to reach USD 280.02 million by 2022 according to a new report by Grand View Research Inc. Growing geriatric population base, increasing global prevalence of cardiovascular diseases, and rising healthcare awareness due to patient education are the driving forces for the PoC Lipid Test industry growth during the forecast period. Furthermore, continuous efforts by the government to reduce hospital stays and curb healthcare expenditure, establishments attempting to provide effective and rapid diagnostic results, and improvement in technology with the provision of cheap and high-quality medical solutions aimed at achieving lab automation are some factors contributing to the growth of the PoC Lipid Test market.Browse full research report on Global Point of Care (PoC) Lipid Test Market: http://www.grandviewresearch.com/industry-analysis/remote-patient-monitoring-devices-marketFurther key findings from the study suggest:Alere Cholestech LDx market was estimated at over 6,400 units in 2014 and is expected to reach over 11,000 units by 2022, growing at a CAGR of 7.8% over the forecast period. The analyzer is included in the CLIA waived test list and is certified by the Cholesterol Reference Method Laboratory Method Network (CRMLN) program and Lipid Standardization Program (LSP)Global launch of Roche Cobas b 101 at the end of 2013 excluding the U.S. region and the introduction of Samsung LABGEO PT10 in the Indian market are expected to drive the point of care Lipid Test market at a lucrative rate over the next six yearsConsumables Piccolo Express by Abaxis market was valued over 1,000 thousand units in 2014 owing to the presence of CLIA-waived capillary or venous lipid and liver panel used for monitoring statin medications results. Abaxis is the only company, which provides a venous or capillary or CLIA waived Lipid and Liver panel.Hyperlipidemia is the largest application area for PoC Lipid Test industry with revenue of over USD 55 million in 2014. Whereas, hypertriglyceridemia is the fastest growing application area with the expected growth rate of 5.6% during the forecast period due to increasing incidences of hypertriglyceridemia and the introduction of technologically advanced products such as CardioChek PA by PTS Diagnostics.Europe constituted the largest share of over 35% in 2014 of the total market. Presence of favorable regulations and initiatives pertaining to the development of healthcare infrastructure, and also high disease prevalence levels in the region are the major factors responsible for its growthAsia Pacific accounted for over 19% share in 2014 of the total market. However, the market share of this region is estimated to increase at a CAGR of 5.8% by 2022 due to increasing demand for rapid diagnostic testing in developing countries such as India and China.Some key players of this market include Abaxis Inc., Roche Diagnostics, Alere Inc., Polymer Technology Systems (PTS Diagnostics), and Samsung Electronics Corporation. Alere with its product portfolio including Alere Cholestech LDx and Alere Afinion AS100 Analyzer was the leader in the POC lipid testing market with a share of over 22% in 2014.Read detailed report or request for free sample of this research report: http://www.grandviewresearch.com/industry-analysis/point-of-care-poc-lipid-test-market/requestGrand View Research has segmented the global PoC Lipid Test market on the basis of instrument, consumables, application, and region:Global PoC Lipid Test Instrument Outlook (Revenue, USD Million, Volume, Units 2015 – 2022)Roche ReflotronRoche Cobas b 101Abaxis PiccoloAlere Cholestech LDXAlere AfinionSamsung LABGEOPTS CardiochekGlobal PoC Lipid Test Consumables Outlook (Revenue, USD Million, Volume, Units 2015 – 2022)Roche ReflotronRoche Cobas b 101Abaxis PiccoloAlere Cholestech LDXAlere AfinionPTS CardiochekSamsung LABGEOGlobal PoC Lipid Test Application Outlook (Revenue, USD Million, 2015 – 2022)HyperlipidemiaHypertriglyceridemiaFamilial HypercholesterolemiaHyperlipoproteinemiaTangier diseaseOthersPoC Lipid Test Market Regional Outlook (Revenue, USD Million, Volume, Units 2015 – 2022)North AmericaU.S.CanadaEuropeUKGermanyAsia PacificJapanChinaAustraliaLatin AmericaBrazilMiddle East and Africa (MEA)South AfricaBrowse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/biotechnology